Free Trial

Aclarion (ACON) Competitors

Aclarion logo
$7.21 -0.09 (-1.23%)
Closing price 03:46 PM Eastern
Extended Trading
$7.19 -0.02 (-0.29%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACON vs. BRTX, BGLC, MGRX, SSY, ATIP, DHAC, NIVF, OTRK, BACK, and BTTX

Should you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), Ontrak (OTRK), IMAC (BACK), and Better Therapeutics (BTTX). These companies are all part of the "healthcare" industry.

Aclarion vs. Its Competitors

Biorestorative Therapies (NASDAQ:BRTX) and Aclarion (NASDAQ:ACON) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

Biorestorative Therapies has a beta of 76.7, indicating that its stock price is 7,570% more volatile than the S&P 500. Comparatively, Aclarion has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500.

In the previous week, Biorestorative Therapies had 1 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for Biorestorative Therapies and 1 mentions for Aclarion. Biorestorative Therapies' average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company Overall Sentiment
Biorestorative Therapies Neutral
Aclarion Neutral

Biorestorative Therapies has a net margin of -1,772.40% compared to Aclarion's net margin of -11,238.59%. Aclarion's return on equity of -83.63% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Biorestorative Therapies-1,772.40% -137.00% -88.31%
Aclarion -11,238.59%-83.63%-76.55%

69.4% of Biorestorative Therapies shares are held by institutional investors. Comparatively, 7.5% of Aclarion shares are held by institutional investors. 30.8% of Biorestorative Therapies shares are held by insiders. Comparatively, 0.8% of Aclarion shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Aclarion has a consensus price target of $11,758.50, indicating a potential upside of 162,985.99%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Biorestorative Therapies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biorestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aclarion
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Aclarion has lower revenue, but higher earnings than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biorestorative Therapies$400K30.52-$8.98M-$1.27-1.20
Aclarion$50K83.64-$6.99MN/AN/A

Summary

Biorestorative Therapies and Aclarion tied by winning 6 of the 12 factors compared between the two stocks.

Get Aclarion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACON vs. The Competition

MetricAclarionMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$4.18M$7.69B$5.74B$9.77B
Dividend YieldN/A2.69%4.40%4.08%
P/E RatioN/A78.4130.4126.04
Price / Sales83.6449.61428.97104.72
Price / CashN/A25.5525.7828.79
Price / Book0.147.619.706.08
Net Income-$6.99M$242.04M$3.27B$265.64M
7 Day Performance2.71%0.02%3.94%3.11%
1 Month Performance-3.48%-0.71%3.81%0.39%
1 Year Performance-99.68%8.50%31.26%18.52%

Aclarion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACON
Aclarion
1.9156 of 5 stars
$7.21
-1.2%
$11,758.50
+162,986.0%
-99.7%$4.18M$50K0.007Gap Down
BRTX
Biorestorative Therapies
1.6802 of 5 stars
$1.54
+1.3%
N/A-10.6%$12.13M$400K-1.217
BGLC
BioNexus Gene Lab
0.0279 of 5 stars
$5.32
-0.4%
N/A+33.5%$9.59M$9.51M0.0030Negative News
MGRX
Mangoceuticals
0.5741 of 5 stars
$1.57
-4.6%
N/A-97.3%$8.48M$620K-0.413
SSY
SunLink Health Systems
N/A$1.12
+16.6%
N/A+38.1%$7.88M$31.09M4.661,376Gap Up
ATIP
ATI Physical Therapy
N/A$0.68
flat
N/A-88.6%$2.98M$741.86M-0.045,600
DHAC
Digital Health Acquisition
N/A$0.78
-9.1%
N/A-52.0%$2.82MN/A0.002,021Gap Up
NIVF
NewGenIvf Group
N/A$1.91
+0.5%
N/A-99.8%$1.64M$5.43M0.00N/APositive News
Gap Down
OTRK
Ontrak
1.7639 of 5 stars
$0.32
-3.0%
$3.00
+837.5%
-97.1%$1.39M$10.85M-0.02250Negative News
Gap Down
BACK
IMAC
N/A$0.10
+38.0%
N/A-95.3%$203K$72.05K0.00180Gap Down
BTTX
Better Therapeutics
N/AN/AN/AN/A$5KN/A0.0040

Related Companies and Tools


This page (NASDAQ:ACON) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners